Cart
Account
Your Orders
Sign In
Meet the Team Engineering the Future
Synthego is a pioneering force in the biotechnology industry, leveraging our expertise to deliver cutting-edge CRISPR and advanced Molecular Diagnostics solutions—all in pursuit of improved human health.
High-quality, scalable solutions for CRISPR research, molecular biology and diagnostic workflows
Accelerating CRISPR-based cell and gene therapy with pioneering solutions
Synthego is a pioneering force in the biotechnology industry, leveraging our expertise to deliver cutting-edge CRISPR and advanced Molecular Diagnostics solutions—all in pursuit of improved human health.
This robust RNA polymerase, derived from the T7 bacteriophage, transcribes RNA from DNA sequences under the control of the T7 promoter.
Protect RNA stability and purity, from research to therapeutic development.
Bringing high fidelity and affordability to your breakthrough cell & gene therapy.
Proven GMP-grade SpCas9 nuclease for your CRISPR-based therapeutics.
Early discovery breakthroughs in therapeutic development begin with research single guide RNA (sgRNA).
Reliable GMP-grade sgRNA for your CRISPR-based therapeutics.
Base editors have promised safer CRISPR therapies, but their clinical translation has faltered owing to their off-target activity. Now, Synthego has partnered with Kactus Biosciences to commercialize AccuBase™ , an...
Synthego is expanding its core mission to accelerate life sciences research and clinical development with the launch of a comprehensive portfolio of high-performance molecular reagents. Building upon our established leadership...
Curious about base editing but not sure where to begin? We’ll break it down step by step, making it easy to follow and apply!